| Original language | Undefined/Unknown |
|---|---|
| Pages (from-to) | 565-571 |
| Number of pages | 7 |
| Journal | British Journal of Cancer |
| Volume | 119 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 2018 |
Cite this
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma. / Gadducci, A.; Grosso, F.; Scambia, G.; Raspagliesi, F.; Colombo, N.; Grignani, G.; Casali, P.; Sanfilippo, R.; Buonadonna, A.; Santoro, A.; Bruzzone, M.; Artioli, G.; Lorusso, D.; Biagioli, E.; Fossati, R.; Galli, F.; Negri, E.; Rulli, E.; Torri, V.; D’Incalci, M.
In: British Journal of Cancer, Vol. 119, No. 5, 2018, p. 565-571.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma
AU - Gadducci, A.
AU - Grosso, F.
AU - Scambia, G.
AU - Raspagliesi, F.
AU - Colombo, N.
AU - Grignani, G.
AU - Casali, P.
AU - Sanfilippo, R.
AU - Buonadonna, A.
AU - Santoro, A.
AU - Bruzzone, M.
AU - Artioli, G.
AU - Lorusso, D.
AU - Biagioli, E.
AU - Fossati, R.
AU - Galli, F.
AU - Negri, E.
AU - Rulli, E.
AU - Torri, V.
AU - D’Incalci, M.
N1 - cited By 0
PY - 2018
Y1 - 2018
U2 - 10.1038/s41416-018-0190-y
DO - 10.1038/s41416-018-0190-y
M3 - Articolo
VL - 119
SP - 565
EP - 571
JO - British Journal of Cancer
JF - British Journal of Cancer
SN - 0007-0920
IS - 5
ER -